U.S. Physical Therapy, Inc. (NYSE:USPH) Director Kathleen A. Gilmartin Purchases 2,000 Shares

U.S. Physical Therapy, Inc. (NYSE:USPHGet Free Report) Director Kathleen A. Gilmartin bought 2,000 shares of U.S. Physical Therapy stock in a transaction on Tuesday, September 3rd. The shares were acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH opened at $86.78 on Friday. The stock has a market cap of $1.31 billion, a PE ratio of 70.55, a price-to-earnings-growth ratio of 4.14 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 1 year low of $78.08 and a 1 year high of $113.63. The firm has a fifty day moving average price of $90.44 and a 200-day moving average price of $98.52. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). The business had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.76 earnings per share. Equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.55 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Friday, August 23rd will be issued a $0.44 dividend. The ex-dividend date is Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a yield of 2.03%. U.S. Physical Therapy’s dividend payout ratio is currently 143.09%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in USPH. Truist Financial Corp raised its holdings in shares of U.S. Physical Therapy by 9.2% during the 2nd quarter. Truist Financial Corp now owns 10,382 shares of the company’s stock worth $960,000 after acquiring an additional 874 shares in the last quarter. Quarry LP grew its holdings in shares of U.S. Physical Therapy by 1,291.9% in the second quarter. Quarry LP now owns 515 shares of the company’s stock valued at $48,000 after purchasing an additional 478 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in U.S. Physical Therapy by 4.5% in the second quarter. The Manufacturers Life Insurance Company now owns 7,248 shares of the company’s stock worth $670,000 after purchasing an additional 309 shares during the last quarter. Marshall Wace LLP raised its stake in U.S. Physical Therapy by 1.1% during the second quarter. Marshall Wace LLP now owns 35,392 shares of the company’s stock valued at $3,271,000 after purchasing an additional 378 shares in the last quarter. Finally, Public Sector Pension Investment Board lifted its position in U.S. Physical Therapy by 7.8% during the second quarter. Public Sector Pension Investment Board now owns 33,134 shares of the company’s stock valued at $3,062,000 after purchasing an additional 2,409 shares during the last quarter.

Analyst Ratings Changes

A number of brokerages have recently issued reports on USPH. Barrington Research cut their price objective on shares of U.S. Physical Therapy from $122.00 to $108.00 and set an “outperform” rating for the company in a research report on Thursday, August 15th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. One equities research analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $112.50.

Read Our Latest Research Report on USPH

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Recommended Stories

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.